Description

Selank is a synthetic heptapeptide (7-amino-acid sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro, or TKPRPGP) developed in Russia by the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a modified analog of the naturally occurring immunomodulatory tetrapeptide tuftsin (found in immunoglobulin G), engineered to provide potent anxiolytic (anti-anxiety), nootropic (cognitive-enhancing), and neuroprotective effects while maintaining immune-modulating properties. Unlike traditional anxiolytics like benzodiazepines, Selank promotes calm without sedation, cognitive impairment, dependence, withdrawal, or amnesia.

Selank has been approved in Russia (and some Eastern European contexts) as a prescription medication, primarily in nasal drop or spray form, for treating generalized anxiety disorder (GAD), neurasthenia, adjustment disorders, and related conditions. It was registered for clinical use around 2009 for anxiety management. Outside Russia, it is not FDA-approved and is available mainly through research peptide suppliers or compounding pharmacies for off-label use as a nootropic or mood support agent.

Key Features and Mechanisms

Selank acts primarily in the central nervous system (CNS) via intranasal administration for rapid brain access (bypassing significant first-pass metabolism):

• Modulates GABAergic neurotransmission (allosteric enhancement of GABA-A receptors) to increase inhibitory effects and reduce neuronal excitability, leading to anxiolytic action without heavy sedation.
• Influences serotonin, dopamine, and enkephalin systems for mood stabilization, reduced fear/aggression, and improved emotional balance.
• Upregulates brain-derived neurotrophic factor (BDNF) expression, supporting neuroplasticity, neuron survival, and cognitive resilience.
• Exhibits immunomodulatory and anti-inflammatory effects (e.g., balancing immune responses, potential antiviral properties in preclinical models).
• Normalizes stress responses and may protect against chronic stress impacts on the brain.

Potential Benefits

• Anxiolytic Effects: Pronounced reduction in anxiety, stress, fear, and aggression; effective for GAD, PTSD symptoms, depression-related anxiety, and situational stress. Provides calm similar to benzodiazepines but without dulling cognition or causing dependence.
• Nootropic/Cognitive Enhancement: Improves mental clarity, focus, attention span, memory (especially working/short-term), learning, and motivation. Helps alleviate brain fog and supports performance under stress.
• Mood and Emotional Support: Potential antidepressant and mood-stabilizing effects; reduces irritability and promotes emotional balance.
• Other Areas: Neuroprotection (e.g., in models of brain injury or chronic alcohol use), immune modulation, reduced inflammation/pain in some contexts, and support during opioid/alcohol withdrawal (preclinical/clinical observations).

Administration and Dosing

• Primary Route: Intranasal (nasal spray or drops) for optimal CNS delivery and fast onset (often 15–30 minutes).
• Typical Dosing (from Russian clinical data, studies, and research/user reports; not medical advice):
  • Nootropic/anxiolytic use in healthy individuals: 250–1,000 mcg (0.25–1 mg) per day, often split into 2–3 doses (e.g., 200–400 mcg per administration).
  • Therapeutic (e.g., anxiety disorders in Russian protocols): Higher, like 750 mcg–3 mg/day (e.g., 2–3 drops of 0.15% solution multiple times daily).
• Cycles: Commonly 10–30 days on, with breaks to maintain efficacy. Start low to assess tolerance.
• Other forms (less common): Subcutaneous injection.

Potential Side Effects

Selank is generally well-tolerated with a favorable safety profile in Russian clinical use and reports:

• Common/mild: Nasal irritation (burning, dryness, congestion, or runny nose; dose-dependent and often transient), mild headaches, dizziness, or nausea (rare).
• Less common: Temporary fatigue, increased anxiety (paradoxical in sensitive individuals or high doses), or minor gastrointestinal upset.
• Rare/long-term: Limited Western data; no significant sedation, dependence, cognitive dulling, or major hormonal disruptions reported. Side effects are typically milder than traditional anxiolytics.

Note: Evidence is strongest from Russian clinical studies (e.g., for GAD and anxiety) and preclinical/animal models, with promising human data but limited large-scale Western trials. It’s not approved outside Russia for most uses, and quality varies with research vendors.

Always consult a qualified healthcare professional before considering Selank or any peptide—individual responses vary, proper sourcing and monitoring are essential, and self-use carries risks. Compared to related peptides like Semax (more cognitive/neuroprotective focus) from your earlier query, Selank emphasizes anxiety relief and calm mood support with strong GABAergic influence. Let me know if you’d like comparisons, stacking ideas, or details on nasal formats!